ESTRADIOL AND PROGESTERONE Drug Patent Profile
✉ Email this page to a colleague
When do Estradiol And Progesterone patents expire, and when can generic versions of Estradiol And Progesterone launch?
Estradiol And Progesterone is a drug marketed by Amneal Pharms and is included in one NDA.
The generic ingredient in ESTRADIOL AND PROGESTERONE is estradiol; progesterone. There are seventy-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estradiol; progesterone profile page.
Summary for ESTRADIOL AND PROGESTERONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 264 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ESTRADIOL AND PROGESTERONE at DailyMed |
Recent Clinical Trials for ESTRADIOL AND PROGESTERONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 4 |
| Fundación Santiago Dexeus Font | Phase 3 |
| El Shatby University Hospital for Obstetrics and Gynecology | Phase 2/Phase 3 |
Pharmacology for ESTRADIOL AND PROGESTERONE
| Drug Class | Estrogen Progesterone |
| Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ESTRADIOL AND PROGESTERONE
US Patents and Regulatory Information for ESTRADIOL AND PROGESTERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | ESTRADIOL AND PROGESTERONE | estradiol; progesterone | CAPSULE;ORAL | 214293-001 | May 16, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
